Cargando…

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

To evaluate the safety and efficacy of bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder. METHODS: Two identical phase 3, randomized, double-blind, placebo-controlled, multicenter clinical trials (RECONNECT) evaluated the safety and efficacy of bremelanoti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kingsberg, Sheryl A., Clayton, Anita H., Portman, David, Williams, Laura A., Krop, Julie, Jordan, Robert, Lucas, Johna, Simon, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Contents
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819021/ https://www.ncbi.nlm.nih.gov/pubmed/31599840 http://dx.doi.org/10.1097/AOG.0000000000003500

Ejemplares similares

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019)

Bremelanotide for Treatment of Female Hypoactive Sexual Desire
por: Edinoff, Amber N., et al.
Publicado: (2022)

Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder
por: Revicki, Dennis A., et al.
Publicado: (2020)

Evaluation and Management of Hypoactive Sexual Desire Disorder
por: Clayton, Anita H., et al.
Publicado: (2018)

Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial
por: Clayton, Anita H, et al.
Publicado: (2016)

Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022)

Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022)

Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin
por: Simon, James A., et al.
Publicado: (2022)

Flibanserin for Treating Hypoactive Sexual Desire Disorder
por: Sang, Jae Hong, et al.
Publicado: (2016)

What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire Disorder
por: Pyke, Robert, et al.
Publicado: (2016)

Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide
por: White, William B., et al.
Publicado: (2017)

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
por: Parish, Sharon J., et al.
Publicado: (2021)

Hypoactive sexual desire disorder caused by antiepileptic drugs
por: Singh, M., et al.
Publicado: (2015)

Women and Men’s Perspectives on the Factors Related to Women’s Dyadic Sexual Desire, and on the Treatment of Hypoactive Sexual Desire Disorder
por: Friedmann, Enav, et al.
Publicado: (2021)

Role of hormones in hypoactive sexual desire disorder and current treatment
por: AlAwlaqi, Ahmed, et al.
Publicado: (2017)

Management of hypoactive sexual desire disorder in women: current and emerging therapies
por: Nappi, Rossella E, et al.
Publicado: (2010)

Flibanserin: A controversial drug for female hypoactive sexual desire disorder
por: Baid, Rashmi, et al.
Publicado: (2018)

Psychometric Properties of the Sexual Interest and Desire Inventory-Female for Diagnosis of Hypoactive Sexual Desire Disorder: The Persian Version
por: Malary, Mina, et al.
Publicado: (2016)

Socio-demographic determinants of low sexual desire and hypoactive sexual desire disorder: a population-based study in Iran
por: Hamzehgardeshi, Zeinab, et al.
Publicado: (2020)

A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes
por: Rochester-Eyeguokan, Charmaine, et al.
Publicado: (2017)

New developments in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin
por: Jayne, Christopher J, et al.
Publicado: (2017)

Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women
por: Cieri-Hutcherson, Nicole E., et al.
Publicado: (2021)

BIOPSYCHOSOCIAL DETERMINANTS OF HYPOACTIVE SEXUAL DESIRE IN WOMEN: A NARRATIVE REVIEW
por: Malary, Mina, et al.
Publicado: (2015)

Melanocortin 4 receptor agonism enhances sexual brain processing in women with hypoactive sexual desire disorder
por: Thurston, Layla, et al.
Publicado: (2022)

Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
por: Thurston, Layla, et al.
Publicado: (2022)

The Effect of Education on Sexual Health of Women with Hypoactive Sexual Desire Disorder: A Randomized Controlled Trial
por: Kaviani, Maasumeh, et al.
Publicado: (2014)

PMON214 Kisspeptin Restores Sexual and Attraction Brain Processing in Women with Hypoactive Sexual Desire Disorder
por: Thurston, Layla, et al.
Publicado: (2022)

Characteristics of Chinese women in need of enhanced sexual health attention and at risk of hypoactive sexual desire disorder
por: Luo, Lan, et al.
Publicado: (2023)

OR17-5 Kisspeptin Increases Penile Tumescence and Sexual Brain Processing in Men with Hypoactive Sexual Desire Disorder
por: Abbara, Ali, et al.
Publicado: (2022)

Acupuncture in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Prospective Cohort Pilot Study
por: Oakley, Susan H., et al.
Publicado: (2016)

Differences in the Gut Microbiome of Women With and Without Hypoactive Sexual Desire Disorder: Case Control Study
por: Li, Guanjian, et al.
Publicado: (2021)

Body Image and Hypoactive Sexual Desire Disorder Relationship in a Representative Sample of Iranian Women
por: Hamzehgardeshi, Zeinab, et al.
Publicado: (2020)

Management of hypoactive sexual desire disorder in women in the gynecological setting: Number 5 - May 2021
por: Lara, Lucia Alves da Silva, et al.
Publicado: (2021)

Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile
por: Maseroli, E., et al.
Publicado: (2023)

Efficacy, Safety, and Tolerability of a New Low-Dose Copper and Nitinol Intrauterine Device: Phase 2 Data to 36 Months
por: Turok, David K., et al.
Publicado: (2020)

Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
por: Mills, Edouard G., et al.
Publicado: (2023)

Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis
por: Kornstein, Susan G., et al.
Publicado: (2017)

The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
por: Uloko, Maria, et al.
Publicado: (2022)

Cognitive-behavioral group therapy for women with hypoactive sexual desire: A pilot randomized study
por: Lerner, Théo, et al.
Publicado: (2022)

Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm
por: Derogatis, Leonard R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s02s0c91bii5c5bv6drf2mlvje